An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies

Aptamer-antibody hybrid complex: Because the oligobody requires only a single antibody and utilizes a simple antigen-antibody reaction, it could offer the benefits of aptamers and antibodies, and may be a potentially valuable tool for cancer therapeutics.155